Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in Germany
| Autor: | Ruof, Jörg, Knoerzer, Dietrich, Dünne, Anja-Alexandra, Dintsios, Charalabos-Markos, Staab, Thomas, Schwartz, Friedrich Wilhelm |
|---|---|
| Zdroj: | In Health policy November 2014 118(2):242-254 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect